Pfizer and BioNTech Release Preliminary Data on Covid-19 Vaccine Candidate
Drugmaker Pfizer and its German partner, BioNTech, have released clinical data on a potential vaccine against COVID-19. Preliminary data from a clinical trial tested the RNA-based COVID-19 vaccine, BNT162b1. The results showed that participants who received the vaccine developed neutralizing antibodies against the virus. While the preliminary data is promising, the findings are currently under peer review. BNT162b1 is one of four vaccine candidates that Pfizer and BioNTech are testing.
Lenovo Unveils its Take on Remote Chronic Disease Monitoring
Lenovo, a computer hardware and technology company, has announced the launch of Lenovo Virtual Care, a remote health monitoring multi-product offering. Released in partnership with Vianova Health, a Florida-based health software company, the platform allows patients to follow their personalized care plans through Lenovo’s devices, connected biometric-monitoring tools, and an AI-based virtual assistant. The offering will hit the US market later this year.
RROCs: Tracking Digital Health Innovation in Response to COVID-19
As we continue to fight through the COVID-19 pandemic, Catalyst @ Health 2.0 is continuing to hold open calls that connect providers with urgent needs to digital health solutions. Rapid Response Open Calls can be launched within days to crowdsource scalable and intelligent health tech solutions from Catalyst’s global network.
Are you a health care provider interested in participating in a subsidized RROC or a health care stakeholder interested in being connected with health tech solutions? Learn more and apply HERE.